These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 9147616
41. Tumor growth modulates macrophage nitric oxide production following paclitaxel administration. Mullins DW, Burger CJ, Elgert KD. Int J Immunopharmacol; 1998 Oct; 20(10):537-51. PubMed ID: 9839658 [Abstract] [Full Text] [Related]
42. Enhanced antitumor effect of recombinant human tumor necrosis factor in combination with recombinant human granulocyte colony-stimulating factor in BALB/c mice. Maeda M, Watanabe N, Tsuji N, Tsuji Y, Okamoto T, Sasaki H, Akiyama S, Niitsu Y. Jpn J Cancer Res; 1993 Aug; 84(8):921-7. PubMed ID: 7691787 [Abstract] [Full Text] [Related]
43. Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis. Hershberger PA, Yu WD, Modzelewski RA, Rueger RM, Johnson CS, Trump DL. Clin Cancer Res; 2001 Apr; 7(4):1043-51. PubMed ID: 11309356 [Abstract] [Full Text] [Related]
44. Kinetics of cisplatin-induced apoptosis in murine mammary and ovarian adenocarcinomas. Meyn RE, Stephens LC, Hunter NR, Milas L. Int J Cancer; 1995 Mar 03; 60(5):725-9. PubMed ID: 7860148 [Abstract] [Full Text] [Related]
46. Intratumoral delivery of encapsulated IL-12, IL-18 and TNF-alpha in a model of metastatic breast cancer. Sabel MS, Su G, Griffith KA, Chang AE. Breast Cancer Res Treat; 2010 Jul 03; 122(2):325-36. PubMed ID: 19802695 [Abstract] [Full Text] [Related]
47. The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis. Naumova E, Ubezio P, Garofalo A, Borsotti P, Cassis L, Riccardi E, Scanziani E, Eccles SA, Bani MR, Giavazzi R. Clin Cancer Res; 2006 Mar 15; 12(6):1839-49. PubMed ID: 16551869 [Abstract] [Full Text] [Related]
48. Cures and partial regression of murine and human tumors by recombinant human tumor necrosis factor. Creasey AA, Reynolds MT, Laird W. Cancer Res; 1986 Nov 15; 46(11):5687-90. PubMed ID: 3756916 [Abstract] [Full Text] [Related]
49. Smac peptide potentiates TRAIL- or paclitaxel-mediated ovarian cancer cell death in vitro and in vivo. Mao HL, Pang Y, Zhang X, Yang F, Zheng J, Wang Y, Liu P. Oncol Rep; 2013 Feb 15; 29(2):515-22. PubMed ID: 23151974 [Abstract] [Full Text] [Related]
50. Flavopiridol increases therapeutic ratio of radiotherapy by preferentially enhancing tumor radioresponse. Mason KA, Hunter NR, Raju U, Ariga H, Husain A, Valdecanas D, Neal R, Ang KK, Milas L. Int J Radiat Oncol Biol Phys; 2004 Jul 15; 59(4):1181-9. PubMed ID: 15234054 [Abstract] [Full Text] [Related]
51. Estrogen receptor α attenuates therapeutic efficacy of paclitaxel on breast xenograft tumors. Chang J, Sui M, Fan W. Breast Cancer Res Treat; 2012 Aug 15; 134(3):969-80. PubMed ID: 22374518 [Abstract] [Full Text] [Related]
52. Hyperthermia enhances the response of paclitaxel and radiation in a mouse adenocarcinoma. Cividalli A, Cruciani G, Livdi E, Pasqualetti P, Tirindelli Danesi D. Int J Radiat Oncol Biol Phys; 1999 May 01; 44(2):407-12. PubMed ID: 10760437 [Abstract] [Full Text] [Related]
53. Does paclitaxel (Taxol) given after (111)In-labeled monoclonal antibodies increase tumor-cumulated activity in epithelial cancers? Miers L, Lamborn K, Yuan A, Richman C, Natarajan A, DeNardo S, DeNardo G. Clin Cancer Res; 2005 Oct 01; 11(19 Pt 2):7158s-7163s. PubMed ID: 16203816 [Abstract] [Full Text] [Related]
54. Pharmacodynamics of immediate and delayed effects of paclitaxel: role of slow apoptosis and intracellular drug retention. Au JL, Li D, Gan Y, Gao X, Johnson AL, Johnston J, Millenbaugh NJ, Jang SH, Kuh HJ, Chen CT, Wientjes MG. Cancer Res; 1998 May 15; 58(10):2141-8. PubMed ID: 9605758 [Abstract] [Full Text] [Related]
55. Synergistic effect of bromocriptine and tumor necrosis factor-alpha on reversing hepatocellular carcinoma multidrug resistance in nude mouse MDR1 model of liver neoplasm. Ding L, Chen XP, Zhang ZW, Guan J, Zhang WG, Wang HP, Wang ZH, Li CL. World J Gastroenterol; 2005 Sep 28; 11(36):5621-6. PubMed ID: 16237754 [Abstract] [Full Text] [Related]
56. Enhancement of tumor radioresponse by docetaxel: Involvement of immune system. Mason K, Staab A, Hunter N, McBride W, Petersen S, Terry N, Milas L. Int J Oncol; 2001 Mar 28; 18(3):599-606. PubMed ID: 11179493 [Abstract] [Full Text] [Related]
57. A novel anti-alpha-fetoprotein single-chain variable fragment displays anti-tumor effects in HepG2 cells as a single agent or in combination with paclitaxel. Ji X, Shen Y, Sun H, Gao X. Tumour Biol; 2016 Aug 28; 37(8):10085-96. PubMed ID: 26820129 [Abstract] [Full Text] [Related]
58. [Expression and significance of heparin binding-epidermal growth factor-like growth factor in paclitaxel-resistant ovarian cancer]. Tang X, Lu M, Li C, Deng S, Li M. Zhonghua Fu Chan Ke Za Zhi; 2014 Jul 28; 49(7):517-22. PubMed ID: 25327734 [Abstract] [Full Text] [Related]
59. Cytotoxicity and apoptosis of ovarian and breast cancer cell lines induced by OVS1 monoclonal antibody and paclitaxel. Moongkarndi P, Kaslungka S, Kosem N, Junnu S, Jongsomboonkusol S, Theptaranon Y, Neungton N. Asian Pac J Allergy Immunol; 2003 Mar 28; 21(1):31-41. PubMed ID: 12931749 [Abstract] [Full Text] [Related]
60. Response and determinants of sensitivity to paclitaxel in human non-small cell lung cancer tumors heterotransplanted in nude mice. Perez-Soler R, Kemp B, Wu QP, Mao L, Gomez J, Zeleniuch-Jacquotte A, Yee H, Lee JS, Jagirdar J, Ling YH. Clin Cancer Res; 2000 Dec 28; 6(12):4932-8. PubMed ID: 11156254 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]